Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Revista médica del Hospital General de México
versión On-line ISSN 2524-177Xversión impresa ISSN 0185-1063
Resumen
GERSON-CWILICH, Raquel et al. Biomarkers associated with coronavirus disease-19 disease progression in a Mexican hospital. Rev. med. Hosp. Gen. Méx. [online]. 2021, vol.84, n.2, pp.64-70. Epub 06-Sep-2021. ISSN 2524-177X. https://doi.org/10.24875/hgmx.20000078.
Introduction:
The Coronavirus disease (COVID-19) pandemic is a worldwide challenge. There are few useful tools to predict patient outcomes. Identification of biomarkers able to predict progression of the disease could improve the treatment of these patients.
Objective:
The objective of the study was to identify biomarkers of disease progression among patients with severe COVID-19 pneumonia.
Materials and methods:
A retrospective cohort study was conducted among severe COVID-19 pneumonia patients hospitalized in the American British Cowdray Medical Center in Mexico City. Disease progression was defined as use of vasoactive amines, need of non-invasive or invasive mechanical ventilation or death. Studied biomarkers included neutrophil/lymphocyte index, lymphocyte/platelet Ratio, C reactive protein, procalcitonin, D Dimer, lactic dehydrogenase (LDH), ferritin, 25-OH-Vitamin D, and interleukin 6.
Results:
We report 46 patients with severe COVID-19 pneumonia. Mean age was 51 years, the majority of whom 30 (65%) male. Median hospitalization was 9 days. 23 (50%) of patients presented disease progression. Ferritin and LDH were strongly associated with disease progression among our cohort. In addition, age was associated with worst prognosis with a relative risk 4.5 (1.2-16.9, p = 0.003).
Conclusions:
Age, ferritin, and LDH were associated with disease progression among patients with severe COVID-19 pneumonia.
Palabras llave : Severe acute respiratory syndrome coronavirus 2; Coronavirus disease-19; Biomarkers; Lactic dehydrogenase; Ferritin; Mexico.